Establishing a National Network of Laboratories Using Next Generation Amplicon Deep Sequencing for BCR-ABL1 Kinase Domain Mutation Screening in Philadelphia Chromosome-Positive Leukemias: the ‘NEXT-IN-CML' Study
Small retrospective studies have suggested that NGS may have several advantages over Sanger sequencing for BCR-ABL1 KD domain mutation screening in Ph+ leukemia patients.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Simona Soverini, Caterina De Benedittis, Luana Bavaro, Margherita Martelli, Stefania Stella, Paolo Vigneri, Anna Serra, Francesca Carnuccio, Santa Errichiello, Sara Galimberti, Claudia Barat รจ, Francesca Lunghi, Fabio Ciceri, Alessandra Lurlo, Nicola Oro Source Type: research